1921
Volume 73, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Subjects in an disease-endemic area in Orissa, India concomitantly infected with filariasis and intestinal helminths had significantly lower intensity of filarial infection in comparison with those who were infected only with filariasis. Administration of albendazole resulted in a significant decrease in the prevalence of filarial antigenemia in subjects concomitantly infected with intestinal helminths, but produced little change in this infection measure in subjects infected only with . These results indicate that intestinal helminths could play a role in the anti-filarial activity of albendazole, most probably by depressing filarial infection intensity in co-infected individuals. Confirmation of these findings in a larger cohort may yield important new insights regarding the role of using albendazole in the ongoing intervention programs for the control of lymphatic filariasis.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2005.73.877
2005-11-01
2017-09-26
Loading full text...

Full text loading...

/deliver/fulltext/14761645/73/5/0730877.html?itemId=/content/journals/10.4269/ajtmh.2005.73.877&mimeType=html&fmt=ahah

References

  1. Ottesen EA, Ismail MM, Horton J, 1999. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 15 : 382–386.
  2. Pani SP, Redy GS, Das LK, Vanamail P, Hoti SL, Ramesh J, Das PK, 2002. Tolerability and efficacy of single dose albendazole, diethylcarbamazxine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wucheria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, south India: a hospital-base study. Filaria J 1 : 1–11.
  3. Dunyo SK, Nkrumah FK, Simonsen PE, 2000. Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment. Trans R Soc Trop Med Hyg 94 : 437–443.
  4. Sarin R, Dash AP, Dua VK, 2004. Albendazole sulphoxide concentrations in plasma of endemic normals from a lymphatic filariasis endemic region using liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 799 : 233–238.
  5. Sahoo PK, Geddam JJB, Satapathy AK, Mohanty MC, Ravindran B, 2000. Bancroftian filariasis: prevalence of antigenaemia and endemic normals in Orissa, India. Trans R Soc Trop Med Hyg 94 : 515–517.
  6. Zeger SL, Liang KY, 1986. The analysis of discrete and continuous longitudinal data. Biometrics 42 : 121–130.
  7. Liang KY, Zeger SL, 1986. Longitudinal data analysis using generalized linear models. Biometrika 73 : 13–22.
  8. Pinheiro JC, Bates DM, 2000. Mixed-Effects Models in S and S-plus. New York: Springer.
  9. Anderson RM, May RM, 1992. Infectious Diseases of Humans. Dynamics and Control. Oxford, United Kingdom: Oxford University Press.
  10. International Filariasis Review Group, (Addiss D, Critchley J, Ejere H, Garner P, Gelband H, Gamble C, 2004. Albendazole for lymphatic filariasis (Cochrane Review). The Cochrane Library, Issue 1. Chichester, United Kingdom: John Wiley & Sons, Ltd.
  11. Collet D, 1991. Modelling Binary Data. London: Chapman & Hall.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2005.73.877
Loading
/content/journals/10.4269/ajtmh.2005.73.877
Loading

Data & Media loading...

  • Received : 28 Jun 2004
  • Accepted : 13 Apr 2005

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error